News

Animal models used in the global effort to find a treatment for COVID-19 must be valid – and they must be used and reported consistently. Society…

The ambitions to conduct more clinical research in the UK could be achieved by strategic investment in the clinical research workforce, according to…

Today, the Society has joined partner organisations in the UK research and innovation sector in calling for competitively costed visas for…

The government has published its COVID-19 recovery strategy, ‘Our plan to rebuild’, setting out a series of phases as part of this plan. Phase three…

A new review, published in the British Journal of Pharmacology, from a team of researchers representing the International Union of Basic and Clinical…

Medicines have been prominent in discussions about the COVID-19 pandemic. There is an urgent need to develop effective treatments to lower risks of…

The Society has responded to the announcement that Gilead Sciences will initiate two phase 3 randomised studies to evaluate the safety and antiviral…

The British Pharmacological Society has responded to concerns that the use of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, could…

As you would expect, we have been carefully monitoring developments in relation to the COVID-19 (coronavirus) pandemic.
 
These are unprecedented times…

The Chancellor of the Exchequer presented his Budget to Parliament on 11 March, announcing a landmark £22bn investment in UK science by 2024-25. The…